GO annotations related to this gene include DNA-binding transcription factor activity. Studies have shown that the triple negative breast cancer inherent interferon regulatory factor IRF9 as a marker of active intratumoral type I and II interferon signaling and reduced risk of distant relapse.[36]. Here, IRF9 is linked to triple-negative breast carcinoma.